Brian J. Amos represents clients in the preparation and prosecution of patent applications worldwide, predominantly in the fields of biotechnology, medical therapeutics, and pharmaceuticals. Specific areas of technological experience include nucleic acid sequencing technologies, nucleotide analogs, siRNA, DNAzymes & ribozymes, antisense oligonucleotides, antibodies and immunotherapies, fusion proteins, vaccines including HIV vaccines, cancer therapies, EEG-based methods, medical devices, medical gas treatments, stem cell-based therapies, cardiac treatments, neurological treatments, diagnostic assays, 3-hybrid assay systems, cell lines, cellular delivery agents, nucleic acid-based nanotechnologies, small molecules, pharmaceutical formulations, and complete syntheses of natural products. Mr. Amos has experience in all aspects of U.S. patent procurement, including reissue, reexamination and interference practice. Mr. Amos also has extensive experience in international prosecution including before the European, Japanese, Canadian and Australian patent offices, as well as European opposition practice.

Mr. Amos received a Ph.D. in Neuroscience from the University of London in 1995, and worked as a research scientist at NYU Medical Center. He graduated Magna Cum Laude from New York Law School in July, 2003. Mr. Amos is admitted to the New York State Bar and is registered to practice before the U.S. Patent and Trademark Office.